Progression Patterns and Post-Progression Survival in Recurred Intrahepatic Cholangiocarcinoma Patients: A Novel Prognostic Nomogram Based on Multicenter Cohorts

被引:2
|
作者
Zhao, Chongyu [1 ]
He, Chaobin [1 ]
Lu, Jiawei [2 ]
Huang, Xin [1 ]
Chen, Cheng [3 ]
Lin, Xiaojun [1 ]
机构
[1] Sun Yat sen Univ, Dept Pancreatobiliary Surg, State Key Lab Oncol South China, Collaborat Innovat Centerfor Canc Med Canc Ctr, Guangzhou, Peoples R China
[2] Dalian Med Univ, Dept Oncol, Hosp 2, Dalian, Peoples R China
[3] Dalian MedicalUnivers, Dept Cardiol, Affiliated Hosp 1, Dalian, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
基金
中国国家自然科学基金;
关键词
intrahepatic cholangiocarcinoma; post-progression survival; recurrence; prognosis; nomogram; HEPATOCELLULAR-CARCINOMA; MANAGEMENT; RESECTION; DIAGNOSIS; PREDICT;
D O I
10.3389/fonc.2022.832038
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundThe post-progression survival (PPS) of recurred intrahepatic cholangiocarcinoma (iCCA) patients relates to the characteristics of tumor progression. Moreover, the prediction model of PPS in those patients has not been well established. This study aimed at developing a novel nomogram for predicting PPS in recurred iCCA patients. MethodClinical characteristics were retrospectively collected in 396 patients diagnosed with iCCA from cohorts of Sun Yat-sen University Cancer Center (SYSUCC) and the First Hospital of Dalian Medical University (FHDMU). The PPS in patients with different progression patterns was investigated. The nomogram of PPS was established with the Cox regression model in the primary cohort. Then the nomogram was verified in the external validation cohort. ResultsLiver progression was the commonest pattern (42.08%) in recurred iCCA patients, while patients with local LN progression had significantly better PPS than those with other patterns. The independent prognostic factors comprised elevated CEA levels, tumor differentiation, N stage 8th, adjuvant therapy, Local LN metastasis, Liver Metastasis only, and Multiple Metastasis. The nomogram constructed on these factors achieved satisfied C-indexes of 0.794 (95% CI 0.769-0.828) and 0.827 (0.779-0.876) for the training and validation cohorts, respectively. These values were significantly higher than those of the 8th TNM stage system (all p < 0.001). The recurred iCCA patients could be precisely classified into high- and low-risk groups according to the cutoff point of this nomogram (p < 0.01). ConclusionThe investigation of progression patterns and the development of this nomogram can offer new evidence to precisely postoperative and post-progression management of iCCA patients.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Clinical impact of post-progression survival on overall survival in elderly patients with extensive disease small-cell lung cancer
    Imai, Hisao
    Mori, Keita
    Watase, Nodoka
    Kazama, Toshifumi
    Fujimoto, Sakae
    Kaira, Kyoichi
    Yamada, Masanobu
    Minato, Koichi
    THORACIC CANCER, 2016, 7 (06) : 655 - 662
  • [42] An MRI-based radiomics nomogram to predict progression-free survival in patients with endometrial cancer
    Liu, Ling
    Ji, Xiaodong
    Liang, Caihong
    Zhu, Jinxia
    Huang, Lixiang
    Zhao, Yujiao
    Xu, Xiangfeng
    Song, Zhiyi
    Shen, Wen
    FUTURE ONCOLOGY, 2024,
  • [43] Post-progression survival is strongly linked to overall survival in refractory small-cell lung cancer patients who received amrubicin
    Imai, Hisao
    Kaira, Kyoichi
    Mori, Keita
    Watase, Nodoka
    Hisada, Takeshi
    Yamada, Masanobu
    Minato, Koichi
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2020, 16 (04) : 764 - 770
  • [44] Post-Progression Survival Is Strongly Linked to Overall Survival in Refractory Small-Cell Lung Cancer Patients Who Received Amrubicin
    Imai, H.
    Kaira, K.
    Mori, K.
    Watase, N.
    Hisada, T.
    Minato, K.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2184 - S2184
  • [45] Construction and validation of a novel prognostic nomogram for predicting overall survival in lung adenocarcinoma patients with different patterns of metastasis
    Xiong, Ying
    Gu, Feifei
    Cui, Jin
    Liu, Yuting
    Sun, Min
    Gu, Xinyue
    Zhong, Luhui
    Zhang, Kai
    Liu, Li
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (16) : 15039 - 15053
  • [46] Cancer-specific survival in patients with cholangiocarcinoma after radical surgery: a Novel, dynamic nomogram based on clinicopathological features and serum markers
    Zhou, Shurui
    Zhao, Yue
    Lu, Yanzong
    Liang, Weiling
    Ruan, Jianmin
    Lin, Lijun
    Lin, Haoming
    Huang, Kaihong
    BMC CANCER, 2023, 23 (01)
  • [47] Clinical impact of post-progression survival in patients with locally advanced non-small cell lung cancer after chemoradiotherapy
    Imai, Hisao
    Kobayashi, Daijiro
    Kaira, Kyoichi
    Kawashima, Sayaka
    Masubuchi, Ken
    Murata, Masumi
    Ebara, Takeshi
    Kitamoto, Yoshizumi
    Minato, Koichi
    RADIOLOGY AND ONCOLOGY, 2022,
  • [48] A Novel Biomarker-Based Preoperative Prognostic Grading System for Predicting Survival After Surgery for Intrahepatic Cholangiocarcinoma
    Tomoaki Yoh
    Satoru Seo
    Etsuro Hatano
    Kojiro Taura
    Hiroaki Fuji
    Yoshinobu Ikeno
    Yukihiro Okuda
    Kentaro Yasuchika
    Toshimi Kaido
    Hideaki Okajima
    Shinji Uemoto
    Annals of Surgical Oncology, 2017, 24 : 1351 - 1357
  • [49] Clinical impact of post-progression survival in patients with locally advanced non-small cell lung cancer after chemoradiotherapy
    Imai, Hisao
    Kobayashi, Daijiro
    Kaira, Kyoichi
    Kawashima, Sayaka
    Masubuchi, Ken
    Murata, Masumi
    Ebara, Takeshi
    Kitamoto, Yoshizumi
    Minato, Koichi
    RADIOLOGY AND ONCOLOGY, 2022, 56 (02) : 228 - 237
  • [50] SWOG 0124: Platinum-Sensitivity Status and Post-Progression Survival in Patients with Extensive-Stage Small Cell Lung
    Lara, Primo
    Miao, Jieling
    Moon, James
    Redman, Mary
    Gandara, David R.
    Kelly, Karen
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S406 - S406